Silvia Stingele

Silvia Stingele has extensive work experience in regulatory affairs, with a focus on global regulatory leadership and program management. Silvia began their career as an Intern Student at the University of Southampton in 2004 before moving on to the role of Diploma Student at St. Jude Children's Research Hospital, where they focused on childhood cancer research and treatment. Silvia then joined the Max Planck Institute of Biochemistry as a Ph.D. Student and Member of the International Max Planck Research School (IMPRS) from 2008 to 2013.

In 2013, Silvia joined Medpace as a Trainee in Clinical Operations/Regulatory Affairs and later became a Regulatory Affairs Associate. Silvia then moved on to Regulis, now PharmaLex, where they worked as a Regulatory Affairs Executive and later as a Senior Regulatory Affairs Executive from 2015 to 2017.

In 2017, Silvia joined Gilead Sciences as an Associate Manager in Regulatory Affairs before moving on to 4SC AG, where they held the roles of Regulatory Affairs Manager and Senior Manager in Regulatory Affairs from 2017 to 2020. At 4SC AG, they gained experience in leading regulatory affairs teams and managing regulatory processes.

Their most recent position was at MorphoSys, where they held the roles of Senior Manager in Regulatory Affairs, Global Regulatory Lead, and Associate Director in Regulatory Affairs, Global Regulatory Program Lead. At MorphoSys, they provided regulatory input for interdisciplinary development teams and played a key role in clinical development. Silvia is a versatile regulatory affairs professional with a strong track record of success in global regulatory leadership and program management.

Silvia Stingele earned a Master's Degree in Biology from Johannes Gutenberg-Universität Mainz, where they studied from 2000 to 2007. Silvia later pursued a Doctor of Philosophy (Ph.D.) in Cell Biology at Ludwig-Maximilians-Universität München, graduating between 2008 and 2013.